Related Experiment Videos
[Estrogen substitution in the postmenopause--effect and compliance]
1Klinik und Poliklinik für Geburtshilfe und Frauenheilkunde, Westfälischen Wilhelms-Universität, Münster.
Therapeutische Umschau. Revue Therapeutique
|November 1, 1994
Summary
Osteoporosis affects one in four women, causing fractures. Long-term estrogen replacement therapy effectively maintains bone mass and prevents osteoporosis in postmenopausal women.
Area of Science:
- Endocrinology
- Gerontology
- Bone Metabolism
Context:
- Osteoporosis is a significant health concern, affecting at least 25% of women and leading to fractures.
- Maintaining bone mass is critical for preventing osteoporosis, particularly in postmenopausal women.
Purpose:
- To evaluate the efficacy of estrogen replacement therapy (ERT) in preventing osteoporosis.
- To explore the role of progestogens in enhancing the antiresorptive effects of estrogens.
Summary:
- Estrogen replacement therapy, including oral estradiol (2 mg) or conjugated estrogens (0.625 mg), and percutaneous estradiol (50-100 mcg), is effective for osteoporosis prevention.
- Concurrent use of progestogen with estrogen may augment antiresorptive effects in women with an intact uterus.
- Improving patient compliance with ERT, currently at 25% in Germany, is crucial for widespread osteoporosis prevention.
Impact:
- Estrogen therapy is a viable strategy for long-term osteoporosis prophylaxis.
- Understanding optimal ERT regimens can reduce fracture risk in postmenopausal women.
- Enhanced patient education on ERT benefits can improve adherence and public health outcomes in menopause management.